VRTX
Vertex Pharmaceuticals IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$112.92B
P/E Ratio
26.39
EPS
$16.86
Beta
0.31
52W High
$507.92
52W Low
$362.50
50-Day MA
$436.75
200-Day MA
$438.43
Dividend Yield
—
Profit Margin
35.50%
Forward P/E
23.42
PEG Ratio
1.67
About Vertex Pharmaceuticals Inc
Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts.
Fundamentals
| Revenue (TTM) | $12.22B |
| Gross Profit (TTM) | $6.65B |
| EBITDA | $4.98B |
| Operating Margin | 38.10% |
| Return on Equity | 24.20% |
| Return on Assets | 12.10% |
| Revenue/Share (TTM) | $47.91 |
| Book Value | $76.18 |
| Price-to-Book | 5.83 |
| Price-to-Sales (TTM) | 9.24 |
| EV/Revenue | 8.81 |
| EV/EBITDA | 21.61 |
| Quarterly Earnings Growth (YoY) | 61.40% |
| Quarterly Revenue Growth (YoY) | 7.80% |
| Shares Outstanding | $253.81M |
| Float | $253.02M |
| % Insiders | 0.20% |
| % Institutions | 98.02% |
Historical Volatility
HV 10-Day
31.73%
HV 20-Day
26.48%
HV 30-Day
24.79%
HV 60-Day
24.13%
HV Rank
46.8%
Volatility is currently expanding
Analyst Ratings
Consensus ($548.69 target)
6
Strong Buy21
Buy5
Hold1
SellMore HEALTHCARE Stocks
Data last updated: 6/13/2026